Vector Science and Therapeutics Corp. (TSXV: PAIN) Files Provisional Patent Application on Integrated Platform for Orthopedic Tissue Regeneration Using Peptides

Platform combines regenerative peptides with autologous platelet-rich biologics, alongside adjunct formulations designed to avoid interfering with the body's own repair cells MEQUON, Wis., Aug. 20, 2026 /PRNewswire/ -- Vector Science and Therapeutics Corp. ("Vector" or the "Company")...